{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:24:07Z","timestamp":1788355447452,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Genetic testing has uncovered rare variants in complement proteins associated with thrombotic microangiopathy (TMA) and C3 glomerulopathy (C3G). Approximately 50% are classified as variants of uncertain significance (VUS). Clinical risk assessment of patients carrying a VUS remains challenging primarily due to a lack of functional information, especially in the context of multiple confounding factors in the setting of kidney transplantation. Our objective was to evaluate the clinicopathologic significance of genetic variants in TMA and C3G in a kidney transplant cohort. We used whole exome next-generation sequencing to analyze complement genes in 76 patients, comprising 60 patients with a TMA and 16 with C3G. Ten variants in complement factor H (<jats:italic>CFH<\/jats:italic>) were identified; of these, four were known to be pathogenic, one was likely benign and five were classified as a VUS (I372V, I453L, G918E, T956M, L1207I). Each VUS was subjected to a structural analysis and was recombinantly produced; if expressed, its function was then characterized relative to the wild-type (WT) protein. Our data indicate that I372V, I453L, and G918E were deleterious while T956M and L1207I demonstrated normal functional activity. Four common polymorphisms in <jats:italic>CFH<\/jats:italic> (E936D, N1050Y, I1059T, Q1143E) were also characterized. We also assessed a family with a pathogenic variant in membrane cofactor protein (<jats:italic>MCP<\/jats:italic>) in addition to <jats:italic>CFH<\/jats:italic> with a unique clinical presentation featuring valvular dysfunction. Our analyses helped to determine disease etiology and defined the recurrence risk after kidney transplant, thereby facilitating clinical decision making for our patients. This work further illustrates the limitations of the prediction models and highlights the importance of conducting functional analysis of genetic variants particularly in a complex clinicopathologic scenario such as kidney transplantation.<\/jats:p>","DOI":"10.3389\/fmed.2021.775280","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:18:33Z","timestamp":1638364713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Zhen","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latisha","family":"Love-Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Java","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000507254","article-title":"Update on C3 glomerulopathy: a complement-mediated disease","volume":"144","author":"Caravaca-Fontan","year":"2020","journal-title":"Nephron."},{"key":"B4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/jcm8070919","article-title":"Outcomes of kidney transplant patients with atypical hemolytic uremic syndrome treated with eculizumab: a systematic review and meta-analysis","volume":"8","author":"Gonzalez Suarez","year":"2019","journal-title":"J Clin Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3389\/fimmu.2019.00337","article-title":"Complement in thrombotic microangiopathies: unraveling ariadne's thread into the labyrinth of complement therapeutics","volume":"10","author":"Gavriilaki","year":"2019","journal-title":"Front Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.ajkd.2018.09.002","article-title":"Kidney transplantation in C3 glomerulopathy: a case series","volume":"73","author":"Regunathan-Shenk","year":"2019","journal-title":"Am J Kidney Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ekir.2019.04.003","article-title":"A multimodality approach to assessing factor I genetic variants in atypical hemolytic uremic syndrome","volume":"4","author":"Java","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/tvst.9.9.37","article-title":"Functional analysis of rare genetic variants in complement factor I (CFI) using a serum-based assay in advanced age-related macular degeneration","volume":"9","author":"Java","year":"2020","journal-title":"Transl Vis Sci Technol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.34067\/KID.0001342020","article-title":"Beyond panel-based testing: exome analysis increases sensitivity for diagnosis of genetic kidney disease","volume":"1","author":"Wilson","year":"2020","journal-title":"Kidney360"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3389\/fimmu.2018.01607","article-title":"Self-damage caused by dysregulation of the complement alternative pathway: relevance of the factor H protein family","volume":"9","author":"Sanchez-Corral","year":"2018","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nsmb.2018","article-title":"Structural basis for engagement by complement factor H of C3b on a self surface","volume":"18","author":"Morgan","year":"2011","journal-title":"Nat Struct Mol Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.4049\/jimmunol.176.6.3725","article-title":"Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation","volume":"176","author":"Liszewski","year":"2006","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"31531","DOI":"10.1038\/srep31531","article-title":"Mapping rare, deleterious mutations in Factor H: association with early onset, drusen burden, and lower antigenic levels in familial AMD","volume":"6","author":"Wagner","year":"2016","journal-title":"Sci Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4049\/jimmunol.1600053","article-title":"FHR3 blocks C3d-mediated coactivation of human B cells","volume":"197","author":"Buhlmann","year":"2016","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1099\/vir.0.80472-0","article-title":"Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology","volume":"86","author":"Wang","year":"2005","journal-title":"J Gen Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/IAI.00254-10","article-title":"Host and pathogen glycosaminoglycan-binding proteins modulate antimicrobial peptide responses in Drosophila melanogaster","volume":"79","author":"Wang","year":"2011","journal-title":"Infect Immun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1084\/jem.20071069","article-title":"Structural basis for complement factor H linked age-related macular degeneration","volume":"204","author":"Prosser","year":"2007","journal-title":"J Exp Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07769","article-title":"Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates","volume":"458","author":"Schneider","year":"2009","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1093\/hmg\/ddw336","article-title":"Protective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degeneration dagger","volume":"25","author":"Yu","year":"2016","journal-title":"Hum Mol Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/jmg.40.9.676","article-title":"Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries","volume":"40","author":"Neumann","year":"2003","journal-title":"J Med Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1086\/318203","article-title":"Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition","volume":"68","author":"Richards","year":"2001","journal-title":"Am J Hum Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/modpathol.2017.90","article-title":"Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies","volume":"30","author":"Gaut","year":"2017","journal-title":"Mod Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MBC.0000000000000793","article-title":"Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes","volume":"30","author":"Marini","year":"2019","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1093\/hmg\/ddv091","article-title":"Rare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levels","volume":"24","author":"Kavanagh","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1006\/jmbi.1993.1381","article-title":"Solution structure of a pair of complement modules by nuclear magnetic resonance","volume":"232","author":"Barlow","year":"1993","journal-title":"J Mol Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat."},{"key":"B35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am J Hum Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.kint.2017.07.015","article-title":"Complete functional characterization of disease-associated genetic variants in the complement factor H gene","volume":"93","author":"Merinero","year":"2018","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.kint.2018.01.037","article-title":"C3 glomerulopathy associated with monoclonal Ig is a distinct subtype","volume":"94","author":"Ravindran","year":"2018","journal-title":"Kidney Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.4049\/jimmunol.1201751","article-title":"Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions","volume":"190","author":"Clark","year":"2013","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1073\/pnas.1017087108","article-title":"Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement","volume":"108","author":"Kajander","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat Chem Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am J Hum Genet."},{"key":"B43","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.ackd.2019.11.003","article-title":"Peri- and post-operative evaluation and management of atypical hemolytic uremic syndrome (aHUS) in kidney transplantation","volume":"27","author":"Java","year":"2020","journal-title":"Adv Chronic Kidney Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"blood","DOI":"10.1182\/blood.2021012037","article-title":"Functional characterization of 105 factor H variants associated with atypical HUS: lessons for variant classification","volume":"2021","author":"Martin Merinero","year":"2021","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.4049\/jimmunol.177.9.6308","article-title":"Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces","volume":"177","author":"Ferreira","year":"2006","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"602284","DOI":"10.3389\/fimmu.2020.602284","article-title":"Functional characterization of rare genetic variants in the n-terminus of complement factor H in aHUS, C3G, and AMD","volume":"11","author":"Wong","year":"2020","journal-title":"Front Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1074\/jbc.M110.211839","article-title":"Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities","volume":"286","author":"Pechtl","year":"2011","journal-title":"J Biol Chem."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.775280\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T13:18:36Z","timestamp":1638364716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.775280\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":47,"alternative-id":["10.3389\/fmed.2021.775280"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.775280","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"775280"}}